BSE Live
Mar 02, 16:01Prev. Close
20.19
Open Price
20.69
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Beryl Drugs (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.06 | 5.06 | 5.04 | 5.04 | 5.04 | |
| Total Share Capital | 5.06 | 5.06 | 5.04 | 5.04 | 5.04 | |
| Reserves and Surplus | 0.50 | 0.48 | 0.46 | 0.44 | 0.43 | |
| Total Reserves and Surplus | 0.50 | 0.48 | 0.46 | 0.44 | 0.43 | |
| Total Shareholders Funds | 5.56 | 5.53 | 5.50 | 5.47 | 5.47 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.11 | 0.15 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.11 | 0.15 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.80 | 0.95 | 0.80 | 0.67 | 0.79 | |
| Trade Payables | 0.95 | 0.79 | 0.51 | 0.84 | 0.93 | |
| Other Current Liabilities | 0.43 | 0.25 | 0.27 | 0.30 | 0.17 | |
| Short Term Provisions | 0.04 | 0.04 | 0.12 | 0.15 | 0.14 | |
| Total Current Liabilities | 2.21 | 2.03 | 1.70 | 1.96 | 2.03 | |
| Total Capital And Liabilities | 7.77 | 7.56 | 7.20 | 7.54 | 7.65 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 2.56 | 2.63 | 2.64 | 2.59 | 2.36 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.03 | 0.25 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 2.56 | 2.63 | 2.64 | 2.62 | 2.61 | |
| Non-Current Investments | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | |
| Deferred Tax Assets [Net] | 0.12 | 0.10 | 0.09 | 0.06 | 0.03 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | |
| Total Non-Current Assets | 3.35 | 3.41 | 3.40 | 3.35 | 3.36 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 1.24 | 1.28 | 1.43 | 1.01 | 0.95 | |
| Trade Receivables | 2.23 | 1.83 | 1.18 | 1.91 | 2.64 | |
| Cash And Cash Equivalents | 0.05 | 0.15 | 0.06 | 0.28 | 0.30 | |
| Short Term Loans And Advances | 0.90 | 0.89 | 1.12 | 0.99 | 0.41 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 4.42 | 4.15 | 3.80 | 4.19 | 4.29 | |
| Total Assets | 7.77 | 7.56 | 7.20 | 7.54 | 7.65 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.92 | 0.89 | 0.01 | 0.01 | 0.01 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.07 | 0.07 | 0.12 | 0.12 | 0.12 | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
10.02.2026
Beryl Drugs Standalone December 2025 Net Sales at Rs 3.78 crore, down 28.86% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y
10.02.2026
Beryl Drugs Standalone December 2025 Net Sales at Rs 3.78 crore, down 28.86% Y-o-Y
14.11.2025
Beryl Drugs Standalone September 2025 Net Sales at Rs 5.12 crore, down 8.8% Y-o-Y
22.08.2025
Beryl Drugs Standalone June 2025 Net Sales at Rs 4.79 crore, down 23.28% Y-o-Y
12.06.2025
Beryl Drugs Standalone March 2025 Net Sales at Rs 3.97 crore, up 33.54% Y-o-Y